Heart failure drug combo shows promise in valve repair study
NCT ID NCT07379788
First seen Jan 31, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This study looked at 180 adults with heart failure and a leaky mitral valve. Researchers compared taking one drug (ARNI) alone versus taking it together with another drug (SGLT2 inhibitor) to see which better improved heart and valve function. The goal was to find a more effective way to manage the disease and reduce strain on the heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Madinah Cardiac Center
Madinah, Saudi Arabia
Conditions
Explore the condition pages connected to this study.